Skip to main content

Funding opportunities

This page contains a list of current funding opportunities offered by other societies, associations and organisations.  If you would like to advertise a funding opportunity on this page, please contact our Education & Careers Officer, Eolan Healy.

Funding opportunities are removed once the application deadline has passed.

You may also find it useful to have a look at our jobs board. In addition to the specific opportunities below, the following websites contain information on sources of funding.

For information relating to funding postgraduate courses and research in the UK:

For information on research funding and fellowship opportunities at all levels in the UK and internationally:

Funding Opportunities

Claude Hannoun Award for best body of work

To advance research in the influenza field by Young scientists, ESWI launched its award for the most promising body of work in flu research. The competition is open to all young scientists throughout the world, and is judged by an international committee spanning all of influenza. The prize is named in honour of Prof Claude Hannoun, founding father of ESWI.

The Best Body of Work Award Winner will receive:

– a cash prize of €10,000

– an invitation to speak at the Seventh ESWI Influenza Conference (Valencia, 13-16 September 2020)

Procedures:
Young Scientists are welcome to apply for the prize. Applicants must have a PhD for no longer than 7 years at the time of the application
Special considerations (for example maternity/paternity leave) are taken into account)
Applicants should submit an executive summary report of their work as well as a proof of status in the form of an official university certificate or letter, which is signed by the supervisor/departmental head before 16 December 2019

Closing Date:
Source:
ESWI
ACTERIA Doctoral Thesis Prizes awarded by EFIS in immunology and allergology

These prizes will honor the best doctoral theses defended in topics related to immunology and allergology in European universities/institutions in the last 3 years prior to the application deadline (December 31, 2019). Hence, applicants who earned their doctoral degree before January 1, 2017 are not eligible. 

 

Candidates for the ACTERIA Doctoral Prizes awarded by EFIS must submit the following:

  • Curriculum Vitae (2 pages max.) with publications, including primary research articles, reviews, book chapters, conference proceedings, oral presentations, etc. (acceptance letter(s) required for publications not yet published or in press)
  • Summary of dissertation including a summary of activity since earning the doctoral degree (3 pages max.)
  • Letter of reference from doctoral degree supervisor
  • Proof of Membership in an EFIS-affiliated National Society
  • Proposed research project (3 Pages max.) including: state-of-the-art, questions addressed, research program and methods, expected results, feasibility, potential bottlenecks and solutions, if necessary, timeline, short list of references.
  • Letter from the Host Institution where the project will be conducted, confirming that appropriate facilities will be guaranteed to the researcher in the event the project is approved, and including a statement that the safety rules of the organization will be applied.
  • Ethics statement (applicable for research using human or animal samples or conducted in humans or animals) confirming that the proposed project will be submitted to the appropriate Institutional Review Board/Ethics Committee before funding is awarded by the Fondation ACTERIA.

The above complementary supporting documents must be submitted as either Word or PDF files.

Note: the names of the uploaded files will be generated automatically by the system.

 

Following the submission deadline, candidates' applications will be forwarded to the EFIS-affiliated National Society to which they belong. Thereafter, National Societies – entrusted with the task of establishing their own selection/nomination panels, if necessary – will review applications and, based on the quality of proposals, ultimately formulate two (2) nominations, one in immunology and one in allergology, to be formally submitted to the ACTERIA Prizes Selection Jury.

 

Prize winners will be announced in May 2020.

Closing Date:
Source:
European Federation of Immunological Societies
Tackling multimorbidity at scale: Understanding disease clusters, determinants & biological pathways

Multimorbidity is associated with a reduction in quality of life, increased use of health services and reduced life expectancy. As the number of conditions an individual has increases, so does the likelihood of increased healthcare costs. Multimorbidity has suffered scientifically from being seen as a random assortment of diseases, making it difficult to address. However, with new understanding of the impact of various factors (including biological, social, behavioural, environmental and others), multimorbidity can be seen as series of non-random clusters of disease.

This will require new multi-disciplinary approaches to mapping and tackling multimorbidity, at scale.

To this end there is:

A Strategic Priorities Fund (SPF) research call, jointly funded by the UK Research and Innovation (UKRI) and the Department of Health and Social Care (DHSC) through the National Institute for Health Research (NIHR), will bring together multi-disciplinary collaborations with a range of scientific, methodological, and clinical knowledge and skills to build manageable, focussed “Multimorbidity Research Collaboratives”. These collaboratives will be expected to have strong patient involvement, as benefits the remit of the project, and add significant understanding to a broad range of topics including, for example:

  • Identification of new disease clusters
  • Multimorbidity over different stages across the life-course taking a comprehensive multi- disciplinary approach
  • Discovery, validation and targeting of underlying mechanistic and pathobiological pathways
  • Recognising the potential to identify new patterns of multimorbidity and contributing factors, and the more advanced nature of research on more established multimorbidity clusters, the call is designed in two streams.

For those groups that need time to consolidate existing data or collaborations and/or obtain preliminary data there is an option to apply for a rapid and modest “Consolidator grant”. These grants will serve as a test bed, bringing new disciplines together and provide proof-of-concept data, enabling the best groupings and ideas to mature to a second “Research Collaborative award” stage.
For those other groups that have already developed multi-disciplinary networks and supporting data, there will be the option to move straight to the “Research Collaborative award” stage.

Consolidator grant:

Up to £1.5 million is available for Consolidator grants. These will be funded for the fixed duration of 6 months; the award amount will be up to £100,000 (RC contribution). All awards are expected to be collaborative and multi-disciplinary in nature. Research teams may build on existing relationships or develop a new collaboration between different researchers and/or resources, for instance, grouping of investigators with single disease expertise branching out to extend their work through newly established links with scientists working on different diseases, methodologists, statisticians, researchers from other disciplines, carers and patient groups.

Research Collaborative award:

Research groups with more mature collaboration links; ownership or existing access to the relevant datasets; and sufficient evidence, underpinned by strong preliminary data, of their ability to perform multimorbidity research at scale, can apply for the Wave 1 Research Collaborative awards, bypassing Consolidator stage. These awards will provide substantial investment to support ambitious studies performed by combinations of partners. Research Collaboratives may include, where appropriate, industry partners, in which case they would require to submit their application as a MRC Industry Collaboration Agreement (please read about the MRC Policy on academic-industry collaborations here). This competition seeks to support a balanced research portfolio of several Research Collaboratives for 2-4 years (£3-5m each).

Closing Date:
Source:
Medical Research Council
GUTS UK: Grants & Awards

GUTS UK are pleased to announce some new and varied research funding opportunities: 

  • GUTS UK/BSG trainee reserach awards
  • GUTS UK development grants
  • GUTS UK nutrition development grants
  • GUTS UK/FORCROHNS development grants
  • The GUTS UK Derek Butler Fellowship
  • GUTS UK Amelie Waring Fellowship
  • GUTS UK/BSPGHAN grants
  • Olympus/GUTS UK Fellowship
  • Parabola/ GUTS UK colorectal cancer research grant
  • GUTS UK/ DR FALK awards
Closing Date:
Varied
Source:
GUTS UK
BMA Foundation for Medical Research – grant categories 2019

All the BMA Foundation for Medical Research grants have National Institute for Health Research (NIHR) partnership status.

Closing Date:
Varied
Source:
British Medical Association
Medical Research Council (MRC) - variety of fellowships, career development awards and research grants

A variety of fellowships, career development awards and research grants opportunities offered by the Medical Research Council.

Closing Date:
Varied
Source:
Medical Research Council
BactiVac Catalyst Training Awards
An open call for BactiVac Network catalyst funding training awards is now OPEN. Funding is available to support training opportunities and exchanges, prioritising those involving LMIC members and academic/industrial partners, for the transfer of knowledge and skills in bacterial vaccinology. Up to £6,000 per award is available and each training visit is expected to be up to three months in duration. The aim of this funding scheme is to support members to train in vaccine research & development (R&D), targeting the main preclinical to clinical area of focus for BactiVac. This catalyst funding scheme will be run up to August 2021. Successful applications could include ones that: • Offer opportunities for both UK and LMIC members to undertake a bilateral exchange, to foster reciprocal relationships between BactiVac members • Address key skills gaps within an LMIC, academic or industrial partners’ institution.
Closing Date:
Ongoing
Source:
BactiVac Network
BactiVac Catalyst Training Awards

An open call for BactiVac Network catalyst funding training awards is now OPEN.  Funding is available to support training opportunities and exchanges, prioritising those involving LMIC members and academic/industrial partners, for the transfer of knowledge and skills in bacterial vaccinology. Up to £6,000 per award is available and each training visit is expected to be up to three months in duration. The aim of this funding scheme is to support members to train in vaccine research & development (R&D), targeting the main preclinical to clinical area of focus for BactiVac.

This catalyst funding scheme will be run up to August 2021. Successful applications could include ones that:

  • Offer opportunities for both UK and LMIC members to undertake a bilateral exchange, to foster reciprocal relationships between BactiVac members
  • Address key skills gaps within an LMIC, academic or industrial partners’ institution.
Closing Date:
Ongoing
Source:
BactiVac Network
Healthy ageing

The healthy ageing challenge will support UK government’s Ageing Society Grand Challenge to ensure people can enjoy at least 5 extra healthy, independent years of life by 2035, while narrowing the gap between the experiences of the richest and poorest.
The aim of this challenge is to enable businesses, including social enterprises, to develop and deliver products, services and business models that will be adopted at scale which support people as they age. This will allow people to remain active, productive, independent and socially connected across generations for as long as possible. Through the challenge, government will bring together UK businesses and researchers to support people to stay in their homes for longer, tackle loneliness, and increase independence and wellbeing.

Up to £98 million will be invested in research and innovation that supports people as they age, while also helping those that care for them.

Over the coming years there will be a series of opportunities for UK-based businesses and researchers. The opportunities range from Trailblazers which will focus on supporting the development of near to market propositions with potential to be adopted at scale; Investment Accelerator and early stage support for businesses looking to develop early-stage innovations; and research to further our understanding of healthy ageing.

The Centre for Ageing Better charity has developed a Healthy Ageing Challenge Framework, to stimulate thinking about the ISCF Healthy Ageing Challenge. It focuses on seven themes to stimulate innovation in pursuit of longer, healthier lives for all

Sustaining physical activity
Maintaining health at work
Design for age-friendly homes
Creating healthy, active places
Supporting social connections
Living well with cognitive impairment
Managing common complaints of ageing.
All funded projects will need to show how they tackle one or more of these challenges of older life


UKRI will provide financial support to academic researchers and small, medium, enterprises working together to develop new products and services. This is early stage innovation activity and it will attract match funding from existing funding streams that focus on digital healthcare and older adults.

Closing Date:
Ongoing
Source:
UKRI
The Advanced Leadership Program

The Advanced Leadership Program is a high-impact and challenging developmental experience for elite female leaders. Over a career-defining, twelve-month journey, participants engage in a deep exploration of their own strengths and weaknesses as they relate to building and leading highly effective organisational communities. Purpose designed to stretch experienced leaders beyond their comfort zone, the ALP challenges participants to develop their critical thinking abilities and begin to unlock their full leadership potential. 


The program employs a multifaceted learning approach based on expert guidance, peer collaboration, self-analysis, experiential exercises and practical application. Theoretical exploration is continually overlaid with real-world experience to ensure that participants develop the adaptive skills needed to confidently overcome future challenges. This process is further enhanced through a combination of executive coaching and peer group mentoring, enabling participants to cultivate valuable peer level networks, build their self-confidence and hone the skills to lead at the highest levels.


Segmented into eleven key themes, the Advanced Leadership Program engages participants in a comprehensive exploration of the responsibilities and opportunities of senior leadership. Through exploring previous experiences, participants gain a deeper understanding of their innate drivers and derailers and develop the skills to take a more adaptive approach to current and future challenges.

Encompassing a sophisticated blend of synchronous and asynchronous learning, the ALP immerses participants in a multilayered development journey designed to ensure maximum individual impact. Coordinated via our state of the art learning management system, the program provides powerful and accessible learning.

All applicants enrolling into the Advanced Leadership Program must satisfy WLI’s admissions criteria and adhere to standard admissions policies and procedures. Enrolments are at the discretion of the WLI Admissions Department. Enrolment details may be obtained by contacting the WLI Admissions Department.

£2,500 Scholarships are available for this program

Closing Date:
Ongoing
Source:
Women and Leadership International

Pages